These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17157649)

  • 1. Biologic immune modifiers: Trials and tribulations--are we there yet?
    Ballow M
    J Allergy Clin Immunol; 2006 Dec; 118(6):1209-15; quiz 1216-7. PubMed ID: 17157649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulators for allergic respiratory disorders.
    Casale TB; Stokes JR
    J Allergy Clin Immunol; 2008 Feb; 121(2):288-96; quiz 297-8. PubMed ID: 18269921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunomodulation therapy for allergic asthma. What is already possible, what is to come?].
    Taube C; Buhl R
    Dtsch Med Wochenschr; 2008 Apr; 133(14):727-32. PubMed ID: 18363195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential adverse events with biologic response modifiers.
    Kong JS; Teuber SS; Gershwin ME
    Autoimmun Rev; 2006 Aug; 5(7):471-85. PubMed ID: 16920574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.
    Owen CE
    Pharmacol Ther; 2007 Jan; 113(1):121-33. PubMed ID: 17000005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 7. Control of allergic airway inflammation through immunomodulation.
    Corry DB; Kheradmand F
    J Allergy Clin Immunol; 2006 Feb; 117(2 Suppl Mini-Primer):S461-4. PubMed ID: 16455347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic therapies for the treatment of asthma.
    Wagelie-Steffen AL; Kavanaugh AF; Wasserman SI
    Clin Chest Med; 2006 Mar; 27(1):133-47, vii. PubMed ID: 16543058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic therapies for asthma.
    Gruenberg D; Busse W
    Curr Opin Pulm Med; 2010 Jan; 16(1):19-24. PubMed ID: 19797955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biological response modifiers in the treatment of immunoinflammatory diseases].
    Skov L; Bendtzen K
    Ugeskr Laeger; 2008 Jun; 170(24):2120-6. PubMed ID: 18565292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newer therapeutic approaches to the vasculitides: biologic agents.
    Samuels J; Spiera R
    Rheum Dis Clin North Am; 2006 Feb; 32(1):187-200, xi. PubMed ID: 16504830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-immunoglobulin E therapy with omalizumab for asthma.
    Hendeles L; Sorkness CA
    Ann Pharmacother; 2007 Sep; 41(9):1397-410. PubMed ID: 17698897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulator therapy: monoclonal antibodies, fusion proteins, cytokines, and immunoglobulins.
    Lee SJ; Chinen J; Kavanaugh A
    J Allergy Clin Immunol; 2010 Feb; 125(2 Suppl 2):S314-23. PubMed ID: 20036416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases.
    Chang TW; Wu PC; Hsu CL; Hung AF
    Adv Immunol; 2007; 93():63-119. PubMed ID: 17383539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin E blockade in the treatment of asthma.
    Kuhn R
    Pharmacotherapy; 2007 Oct; 27(10):1412-24. PubMed ID: 17896896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms in allergic airway inflammation - lessons from studies in the mouse.
    Shum BO; Rolph MS; Sewell WA
    Expert Rev Mol Med; 2008 May; 10():e15. PubMed ID: 18503727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease.
    Séguin RM; Ferrari N
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1505-17. PubMed ID: 19715448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New perspectives in the treatment of allergic rhinitis and asthma in children.
    Baena-Cagnani CE; Passalacqua G; Gómez M; Zernotti ME; Canonica GW
    Curr Opin Allergy Clin Immunol; 2007 Apr; 7(2):201-6. PubMed ID: 17351477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of anti-immunoglobulin E therapy with omalizumab in allergic patients at risk of geohelminth infection.
    Cruz AA; Lima F; Sarinho E; Ayre G; Martin C; Fox H; Cooper PJ
    Clin Exp Allergy; 2007 Feb; 37(2):197-207. PubMed ID: 17250692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asthma treatment: 'magic bullets which seek their own targets'.
    Tarantini F; Baiardini I; Passalacqua G; Braido F; Canonica GW
    Allergy; 2007 Jun; 62(6):605-10. PubMed ID: 17508963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.